Jobst Vascular Center, Toledo, Ohio, USA.
J Vasc Surg. 2010 May;51(5):1209-14. doi: 10.1016/j.jvs.2009.12.021. Epub 2010 Mar 27.
International treatment guidelines now recognize the importance of thrombus removal to reduce postthrombotic morbidity when treating patients with extensive acute deep venous thrombosis (DVT). Studies have shown that thrombus resolution with catheter-directed thrombolysis in patients with iliofemoral DVT reduces postthrombotic morbidity, although patients unsuccessfully treated with catheter-directed thrombolysis (CDT) do not enjoy the same long-term benefit. The purpose of this study is to objectively assess whether the amount of clot reduction at the time of acute therapy correlates with long-term postthrombotic morbidity.
Forty-two patients who underwent catheter-directed and/or pharmacomechanical lysis of iliofemoral DVT were quantitatively evaluated. Patients had their degree of clot lysis quantified and were divided into two main groups for comparison. Group I (n = 33) had >50% clot lysis (mean, 84%) and group II (n = 9) had < or =50% lysis (mean, 42%). At a mean follow-up interval of 14 months, the degree of chronic venous disease was assessed by evaluators blinded to the degree of clot lysis. Evaluation of postthrombotic morbidity was performed using the Villalta scale, and the clinical class of CEAP, and quality-of-life (QOL) was assessed using the Short Form Health Survey (SF-36).
Mean CEAP scores were 0.85 and 3.13 (P = .005), and Villalta scores were 2.38 and 6.25 (P = .009) in group I and group II, respectively. Patient QOL in group I was higher than group II in all parameters. Physical functioning (P = .035), role physical (P = .012), general health (P = .014), vitality (P < .001), and social functioning (P = .012) were all significantly better in group I. Bodily pain (P = .117), role emotional (P = .624), and mental health (P = .096) strongly favored group I patients but did not reach statistical significance.
Patients with extensive DVT treated with catheter-based interventions to eliminate thrombus suffer relatively little postthrombotic morbidity. The degree of clot lysis directly correlates with long-term outcome. Improved QOL, the Villalta scale, and clinical class of CEAP are linearly correlated with the amount of clot resolution.
国际治疗指南现在认识到,在治疗广泛急性深静脉血栓形成(DVT)患者时,去除血栓以降低血栓后发病率的重要性。研究表明,导管溶栓治疗髂股 DVT 患者的血栓溶解可降低血栓后发病率,尽管经导管溶栓治疗(CDT)失败的患者不能享受同样的长期益处。本研究的目的是客观评估急性治疗时血栓减少的程度是否与长期血栓后发病率相关。
对 42 例接受导管溶栓和/或药物机械溶栓治疗的髂股 DVT 患者进行定量评估。对患者的血栓溶解程度进行量化,并分为两组进行比较。组 I(n = 33)的血栓溶解率>50%(平均 84%),组 II(n = 9)的血栓溶解率≤50%(平均 42%)。在平均 14 个月的随访期内,由对血栓溶解程度不知情的评估者评估慢性静脉疾病的程度。使用 Villalta 量表评估血栓后发病率,使用健康调查简表(SF-36)评估临床 CEAP 分类和生活质量(QOL)。
组 I 和组 II 的平均 CEAP 评分分别为 0.85 和 3.13(P =.005),Villalta 评分分别为 2.38 和 6.25(P =.009)。组 I 的患者 QOL 在所有参数上均高于组 II。身体功能(P =.035)、角色身体(P =.012)、总体健康(P =.014)、活力(P <.001)和社会功能(P =.012)在组 I 中均显著更好。躯体疼痛(P =.117)、角色情感(P =.624)和心理健康(P =.096)强烈有利于组 I 患者,但未达到统计学意义。
接受基于导管的干预措施消除血栓的广泛 DVT 患者血栓后发病率相对较低。血栓溶解的程度与长期结果直接相关。QOL、Villalta 量表和 CEAP 临床分类的改善与血栓溶解量呈线性相关。